
Monterosa Therapeutics is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader (MGD) medicines for serious diseases including oncology, autoimmune, and inflammatory conditions. Utilizing the QuEEN™ discovery engine, which integrates AI-guided chemistry, structural biology, and proteomics, Monterosa identifies and designs MGDs with unparalleled selectivity, enabling access to a diverse range of validated therapeutic targets. The company boasts an industry-leading pipeline of MGDs, positioning it as a pioneer in precision medicine.
We are seeking an enthusiastic, creative, and highly talented medicinal chemist to lead our drug discovery projects from Lead Identification through development candidate nomination and beyond.
Monterosa Therapeutics is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader (MGD) medicines for serious diseases including oncology, autoimmune, and inflammatory conditions. Utilizing the QuEEN™ discovery engine, which integrates AI-guided chemistry, structural biology, and proteomics, Monterosa identifies and designs MGDs with unparalleled selectivity, enabling access to a diverse range of validated therapeutic targets. The company boasts an industry-leading pipeline of MGDs, positioning it as a pioneer in precision medicine.
Monterosa